Prospective open label non-comparative study of the safety, efficacy and tolerability of high dose ritonavir/lopinavir [lopinavir/ritonavir; Kaletra] liquid in salvage therapy for PI [protease inhibitor] resistant HIV & a PK [pharmacokinetic] equivalence sub-study of high dose ritonavir/lopinavir capsules

Trial Profile

Prospective open label non-comparative study of the safety, efficacy and tolerability of high dose ritonavir/lopinavir [lopinavir/ritonavir; Kaletra] liquid in salvage therapy for PI [protease inhibitor] resistant HIV & a PK [pharmacokinetic] equivalence sub-study of high dose ritonavir/lopinavir capsules

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Antiretrovirals; Lopinavir/ritonavir
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top